# OnCo record upifitamab-rilsodotin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/upifitamab-rilsodotin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "upifitamab-rilsodotin" ;
  schema:name "Upifitamab rilsodotin"@en ;
  schema:alternateName "XMT-1536"@en, "UpRi"@en ;
  schema:description "Upifitamab rilsodotin is an antibody-drug conjugate from Mersana Therapeutics, in registered phase 2 trials for ovarian cancer, non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/upifitamab-rilsodotin/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Upifitamab%20rilsodotin> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/mersana/> ;
  onco:trials <https://onco.cc/trials/nct03319628/> .